Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
About
9M India manufactures a comprehensive range of gastrointestinal hard gelatin capsules at its WHO-GMP certified facility in Birkoni, Chhattisgarh. Gastrointestinal disorders represent one of the most common disease burden categories globally, with consistently high demand for proton pump inhibitors, antidiarrhoeals, antispasmodics and laxative formulations across all markets. Our GI capsule portfolio covers PPIs (Omeprazole, Lansoprazole, Pantoprazole), antidiarrhoeals (Loperamide), antispasmodics (Dicyclomine), and combination GI formulations — all manufactured as enteric-coated pellet or standard hard gelatin capsules to BP/USP pharmacopoeial standards with full stability data and export documentation.

Our gastrointestinal drugs capsule range covers the following sub-categories and key molecules:
| Sub-Category | Key Molecules |
| Proton Pump Inhibitors (PPIs) | Omeprazole 20mg / 40mg, Lansoprazole 15mg / 30mg, Pantoprazole 40mg, Esomeprazole 20mg / 40mg |
| Antidiarrhoeals | Loperamide HCl 2mg |
| Antispasmodics | Dicyclomine HCl 10mg / 20mg, Mebeverine HCl 135mg |
| Combination GI | Pantoprazole + Domperidone, Omeprazole + Domperidone, Rabeprazole + Levosulpiride SR |
| H2 Blockers | Famotidine 20mg / 40mg, Ranitidine 150mg |
| Antiflatulents / Antacids | Simethicone combinations, Aluminium Hydroxide combinations |
| Prokinetics | Domperidone 10mg, Itopride HCl 50mg |
WHY 9M INDIA FOR GASTROINTESTINAL DRUGS
PPI molecules including Omeprazole, Lansoprazole and Pantoprazole are acid-labile and require enteric-coated pellet capsule formulation to protect the active ingredient from gastric acid degradation. 9M India manufactures enteric-coated pellet capsules with full dissolution validation data, coating uniformity records and multi-point pH-change dissolution profiles.
9M India manufactures all four major PPIs — Omeprazole, Lansoprazole, Pantoprazole and Esomeprazole — plus combination PPI + Domperidone and PPI + Levosulpiride formulations. Export buyers can source their complete PPI portfolio from a single WHO-GMP certified supplier.
Fixed-dose combination GI capsules — such as Pantoprazole + Domperidone and Rabeprazole + Levosulpiride SR — command better market positioning and compliance in markets where patients prefer combination therapy. 9M India manufactures these alongside standalone molecules for a complete GI portfolio.
Molecule Grid
Omeprazole 20mg | Gastrointestinal | Enteric-coated pellet capsule | PPI
Omeprazole 40mg | Gastrointestinal | Enteric-coated pellet capsule | PPI
Lansoprazole 15mg / 30mg | Gastrointestinal | Enteric-coated pellet capsule | PPI
Pantoprazole 40mg | Gastrointestinal | Enteric-coated pellet capsule | PPI
Esomeprazole 20mg / 40mg | Gastrointestinal | Enteric-coated pellet capsule | PPI
Loperamide HCl 2mg | Gastrointestinal | Hard gelatin capsule | Antidiarrhoeal
Dicyclomine HCl 10mg / 20mg | Gastrointestinal | Hard gelatin capsule | Antispasmodic
Domperidone 10mg | Gastrointestinal | Hard gelatin capsule | Prokinetic
Famotidine 20mg / 40mg | Gastrointestinal | Hard gelatin capsule | H2 Blocker
Pantoprazole + Domperidone | Gastrointestinal combination | Capsule | PPI + Prokinetic
Export markets & regulatory
9M India exports gastrointestinal capsules to 15+ countries across Phase 1 markets including the UAE, Iraq, Egypt, Mexico, Russia, Kazakhstan and others in the Middle East, CIS, Africa and ASEAN. PPIs, antidiarrhoeals and antispasmodics are consistently among the top-volume essential medicines in these markets.
WHO-GMP Certificate
DCGI Manufacturing Licence
Certificate of Pharmaceutical Product (CoPP)
Certificate of Analysis (CoA) — batch-wise
CTD / ACTD Dossier — on request
Stability Data — ICH Zone IVb (30°C/75% RH)
Whether you are sourcing PPIs, antidiarrhoeals, antispasmodics or combination GI capsules — for institutional supply, government tenders or export distribution — 9M India delivers WHO-GMP certified manufacturing with complete documentation and enteric-coated pellet capsule expertise.
WHO-GMP
Certified
1,000+
Formulations
15+ Countries
Supplied
DCGI
Approved
Therapeutic Categories
Our capsule portfolio covers the therapeutic areas with the highest demand across domestic distribution, institutional supply and international export markets.
We keep answer short
01
Yes. 9M India manufactures Omeprazole, Lansoprazole, Pantoprazole and Esomeprazole as enteric-coated pellet hard gelatin capsules at its WHO-GMP certified facility. The enteric-coated pellet design is essential for PPI molecules to protect them from gastric acid and ensure full bioavailability in the small intestine.
02
9M India manufactures all four major PPIs: Omeprazole (20mg / 40mg), Lansoprazole (15mg / 30mg), Pantoprazole (40mg) and Esomeprazole (20mg / 40mg). Combination PPI formulations including Pantoprazole + Domperidone and Rabeprazole + Levosulpiride SR are also available.
03
Yes. 9M India manufactures Loperamide Hydrochloride 2mg hard gelatin capsules — a WHO Essential Medicine for the symptomatic treatment of acute and chronic diarrhoea. Loperamide is in consistent demand across all our export markets, particularly in Africa and ASEAN.
04
Yes. 9M India manufactures fixed-dose combination GI capsules including Pantoprazole + Domperidone and Omeprazole + Domperidone. These combination formulations address both acid suppression and gastric motility in one capsule and are widely used across South Asian and Middle Eastern markets.
05
Documentation available includes WHO-GMP Certificate, DCGI Manufacturing Licence, CoPP, batch CoA, ICH Zone IVb stability data (including dissolution profiles for enteric-coated formulations) and CTD/ACTD dossiers on request for all gastrointestinal capsule formulations.